# ALOGLIPTIN; METFORMIN HYDROCHLORIDE
> **ANDA210160** · Abbreviated New Drug Application (Generic) · Sponsor: TORRENT PHARMS LTD · Approved 2018-12-19
## Drug
- **FDA Application Number:** ANDA210160
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ALOGLIPTIN; METFORMIN HYDROCHLORIDE
- **Generic name:** Alogliptin
- **Active ingredients:** ALOGLIPTIN; METFORMIN HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** TORRENT PHARMS LTD
- **First approval:** 2018-12-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210160)
---
*AI Analytics · CC0 1.0*